Cleared Traditional

K253726 - uAngio AVIVA CX

K253726 is an FDA 510(k) clearance for uAngio AVIVA CX, manufactured by Shanghai United Imaging Healthcare Co., Ltd.. The device is a Class 2 Radiology device with product code OWB cleared through the Traditional 510(k) pathway after a 270-day FDA review.

K253726 · Shanghai United Imaging Healthcare Co., Ltd. · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 2026
Decision
270d
Days
Class 2
Risk

K253726 is an FDA 510(k) clearance for the uAngio AVIVA CX. Classified as Interventional Fluoroscopic X-ray System (product code OWB), Class II - Special Controls.

Submitted by Shanghai United Imaging Healthcare Co., Ltd. (Shanghai, CN). The FDA issued a Cleared decision on August 21, 2026 after a review of 270 days - an extended review cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.1650 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Radiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Shanghai United Imaging Healthcare Co., Ltd. devices

FDA 510(k) Submission Details - K253726

510(k) Number K253726 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 24, 2025
Decision Date August 21, 2026
Days to Decision 270 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
163d slower than avg
Panel avg: 107d · This submission: 270d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

OWB Device Classification - Class 2, Special Controls

Product Code OWB Interventional Fluoroscopic X-ray System
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.1650
Definition Interventional Fluoroscopy
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - OWB Interventional Fluoroscopic X-ray System

All 292
Devices cleared under the same product code (OWB) and FDA review panel - the closest regulatory comparables to K253726.
EXTRON 3
K261413 · DRTECH Corporation · Aug 2026
Zenition 30
K254205 · Philips Medical Systems Nederland B.V. · Aug 2026
Shield System (Siemens 30x40)
K260607 · Radiaction , Ltd. · Jul 2026
SmartCT (R3.0 (L10))
K253670 · Philips Medical Systems B.V. · Jul 2026
C-beam
K252735 · Pulmera, Inc. · May 2026
Intelligent NR
K252503 · Canon, Inc. · Apr 2026